A new strategy to beat lung cancer: Chemists develop first-in-class inhibitor targeting a key epigenetic regulator
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a first-in-class chemical inhibitor that precisely and selectively targets the ATAC complex, a critical cellular ...
7 hours ago
0
9









